Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated:  11/14/2017
University of Texas Medical Branch
mi
from
Galveston, TX
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated: 11/14/2017
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated:  11/14/2017
Allison Cancer Center
mi
from
Midland, TX
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated: 11/14/2017
Allison Cancer Center
mi
from
Midland, TX
Click here to add this to my saved trials
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated:  11/14/2017
Northwestern Medical Specialists, PLLC
mi
from
Tacoma, WA
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated: 11/14/2017
Northwestern Medical Specialists, PLLC
mi
from
Tacoma, WA
Click here to add this to my saved trials
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated:  11/14/2017
Henry Ford Health System
mi
from
Detroit, MI
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated: 11/14/2017
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated:  11/14/2017
University of Cincinnati Physicians, Inc
mi
from
Cincinnati, OH
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated: 11/14/2017
University of Cincinnati Physicians, Inc
mi
from
Cincinnati, OH
Click here to add this to my saved trials
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated:  11/14/2017
Cancer Centers of the Carolinas
mi
from
Greenville, SC
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated: 11/14/2017
Cancer Centers of the Carolinas
mi
from
Greenville, SC
Click here to add this to my saved trials
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated:  11/14/2017
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
An Open-Label Randomized, Phase 2A, Dose-ranging Study of Sotatercept (ACE-011) for Chemotherapy-Induced Anemia in Subjects With Advanced or Metastatic Solid Tumors Treated With Platinum-Based Chemotherapeutic Regimens
Status: Enrolling
Updated: 11/14/2017
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
Click here to add this to my saved trials
BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
A Randomized, Double-blind, Double-dummy, Placebo-controlled Study of Oral BGS649 Monotherapy Assessing Safety and Tolerability in Patients With Moderate to Severe Endometriosis
Status: Enrolling
Updated:  11/16/2017
Novartis Investigative Site
mi
from
Anaheim, CA
BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
A Randomized, Double-blind, Double-dummy, Placebo-controlled Study of Oral BGS649 Monotherapy Assessing Safety and Tolerability in Patients With Moderate to Severe Endometriosis
Status: Enrolling
Updated: 11/16/2017
Novartis Investigative Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
San Diego, CA
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Clearwater, FL
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
North Miami, FL
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Roswell, GA
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Detroit, MI
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Saginaw, MI
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Saginaw, MI
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
LawrenceVille, NJ
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
LawrenceVille, NJ
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Plainsboro, NJ
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Plainsboro, NJ
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
New Bern, NC
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
New Bern, NC
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Philadelphia, PA
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Jackson, TN
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Houston, TX
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
San Antonio, TX
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated:  11/16/2017
Clinical Research Facility
mi
from
Seattle, WA
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis
Status: Enrolling
Updated: 11/16/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
Status: Enrolling
Updated:  11/17/2017
Cleveland Clinic
mi
from
Weston, FL
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
Status: Enrolling
Updated: 11/17/2017
Cleveland Clinic
mi
from
Weston, FL
Click here to add this to my saved trials
Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)
Vitamin D Supplementation in Polycystic Ovary Syndrome: a Randomized Controlled Trial.
Status: Enrolling
Updated:  11/20/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)
Vitamin D Supplementation in Polycystic Ovary Syndrome: a Randomized Controlled Trial.
Status: Enrolling
Updated: 11/20/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue
Prospective Evaluation of the Impact of Bacterial Vaginosis and Its Treatment on Mucosal Susceptibility to HIV-1 Infection and Endpoints of Cervico-Vaginal Safety
Status: Enrolling
Updated:  11/20/2017
Eastern Virginia Medical School CONRAD Clinical Research Center
mi
from
Norfolk, VA
Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue
Prospective Evaluation of the Impact of Bacterial Vaginosis and Its Treatment on Mucosal Susceptibility to HIV-1 Infection and Endpoints of Cervico-Vaginal Safety
Status: Enrolling
Updated: 11/20/2017
Eastern Virginia Medical School CONRAD Clinical Research Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
Preventing Postpartum Depression in Prenatal Care
Bellevue ROSE: Preventing Postpartum Depression in Prenatal Care
Status: Enrolling
Updated:  11/20/2017
New York University School of Medicine
mi
from
New York, NY
Preventing Postpartum Depression in Prenatal Care
Bellevue ROSE: Preventing Postpartum Depression in Prenatal Care
Status: Enrolling
Updated: 11/20/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
An Exploratory Clinical Trial of Zoledronic Acid in Women With CIN 2/3 or 3
Status: Enrolling
Updated:  11/21/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
An Exploratory Clinical Trial of Zoledronic Acid in Women With CIN 2/3 or 3
Status: Enrolling
Updated: 11/21/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy of Acetaminophen in Posterior Fossa Surgery
Efficacy of Intravenous Acetaminophen as Analgesic Adjuvant Therapy in Children Undergoing Posterior Fossa Surgery
Status: Enrolling
Updated:  11/22/2017
Children's National Health System
mi
from
Washington,
Efficacy of Acetaminophen in Posterior Fossa Surgery
Efficacy of Intravenous Acetaminophen as Analgesic Adjuvant Therapy in Children Undergoing Posterior Fossa Surgery
Status: Enrolling
Updated: 11/22/2017
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Erlotinib in Combination With Cisplatin as Radiosensitizing Agents in Women Receiving Radiation Therapy for Locally Advanced Squamous Cell Carcinoma of the Cervix; A Phase I Trial
Status: Enrolling
Updated:  11/27/2017
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Erlotinib in Combination With Cisplatin as Radiosensitizing Agents in Women Receiving Radiation Therapy for Locally Advanced Squamous Cell Carcinoma of the Cervix; A Phase I Trial
Status: Enrolling
Updated: 11/27/2017
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
DNA Array Analysis of Patients With Cervical Cancer
A Pilot Study of Early Changes in DNA Array Expression Following Chemo-Radiation Treatment of Cervical Cancer
Status: Enrolling
Updated:  11/28/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
DNA Array Analysis of Patients With Cervical Cancer
A Pilot Study of Early Changes in DNA Array Expression Following Chemo-Radiation Treatment of Cervical Cancer
Status: Enrolling
Updated: 11/28/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery
Status: Enrolling
Updated:  11/28/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery
Status: Enrolling
Updated: 11/28/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Smart Textile Technology for Scoliosis
Smart Textile Technology for Scoliosis: Aim 1
Status: Enrolling
Updated:  11/29/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Smart Textile Technology for Scoliosis
Smart Textile Technology for Scoliosis: Aim 1
Status: Enrolling
Updated: 11/29/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
A Phase I Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
Status: Enrolling
Updated:  11/29/2017
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
A Phase I Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
Status: Enrolling
Updated: 11/29/2017
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Magnesium Sulfate vs Placebo for Placental Abruption
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
Status: Enrolling
Updated:  12/1/2017
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Magnesium Sulfate vs Placebo for Placental Abruption
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
Status: Enrolling
Updated: 12/1/2017
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Magnesium Sulfate vs Placebo for Placental Abruption
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
Status: Enrolling
Updated:  12/1/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Magnesium Sulfate vs Placebo for Placental Abruption
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
Status: Enrolling
Updated: 12/1/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Phase II Study of 852A Administered Subcutaneously in Patients With Metastatic Refractory Breast, Ovarian, Endometrial and Cervical Cancers
Status: Enrolling
Updated:  12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Phase II Study of 852A Administered Subcutaneously in Patients With Metastatic Refractory Breast, Ovarian, Endometrial and Cervical Cancers
Status: Enrolling
Updated: 12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial
Status: Enrolling
Updated:  12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial
Status: Enrolling
Updated: 12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial
Status: Enrolling
Updated:  12/3/2017
Crozer-Chester Medical Center
mi
from
Upland, PA
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial
Status: Enrolling
Updated: 12/3/2017
Crozer-Chester Medical Center
mi
from
Upland, PA
Click here to add this to my saved trials
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
WCC# 44: A Pilot Study of CerviPrep, a Novel Drug Delivery Device for the Cervix, in the Local Administration of Gemcitabine, a Radiation Sensitizer
Status: Enrolling
Updated:  12/3/2017
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
WCC# 44: A Pilot Study of CerviPrep, a Novel Drug Delivery Device for the Cervix, in the Local Administration of Gemcitabine, a Radiation Sensitizer
Status: Enrolling
Updated: 12/3/2017
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase I Study of MEK Inhibitor MEK162 Combined With Idarubicin and Cytarabine Induction in Patients With Relapsed/Refractory RAS-Mutated Acute Myeloid Leukemia
Status: Enrolling
Updated:  12/4/2017
Stanford University School of Medicine
mi
from
Stanford, CA
MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase I Study of MEK Inhibitor MEK162 Combined With Idarubicin and Cytarabine Induction in Patients With Relapsed/Refractory RAS-Mutated Acute Myeloid Leukemia
Status: Enrolling
Updated: 12/4/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Feasibility of a Touch Screen Computer Based Breast-feeding Educational Support Program
Feasibility of a Touch Screen Computer Based Breast-feeding Educational Support Program
Status: Enrolling
Updated:  12/4/2017
Regional West Medical Center-University of Nebraska Medical Center
mi
from
Scottsbluff, NE
Feasibility of a Touch Screen Computer Based Breast-feeding Educational Support Program
Feasibility of a Touch Screen Computer Based Breast-feeding Educational Support Program
Status: Enrolling
Updated: 12/4/2017
Regional West Medical Center-University of Nebraska Medical Center
mi
from
Scottsbluff, NE
Click here to add this to my saved trials
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management on High-Risk Pregnancy Outcomes
Status: Enrolling
Updated:  12/5/2017
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management on High-Risk Pregnancy Outcomes
Status: Enrolling
Updated: 12/5/2017
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated:  12/6/2017
Clinical Research Facility
mi
from
San Diego, CA
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated: 12/6/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated:  12/6/2017
Clinical Research Facility
mi
from
San Francisco, CA
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated: 12/6/2017
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated:  12/6/2017
Clinical Research Facility
mi
from
Torrance, CA
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated: 12/6/2017
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated:  12/6/2017
Clinical Research Facility
mi
from
New Haven, CT
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated: 12/6/2017
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated:  12/6/2017
Clinical Research Facility
mi
from
Clearwater, FL
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated: 12/6/2017
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated:  12/6/2017
Clinical Research Facility
mi
from
Gainesville, FL
Bay98-7196, Dose Finding / POC Study
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status: Enrolling
Updated: 12/6/2017
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials